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Conductive and protein resistant polypyrrole films
for dexamethasone delivery
B. Zhang, P. J. Molino, A. R. Harris, Z. Yue, S. E. Moulton*† and G. G. Wallace*
The development of inherently conducting polymers as controllable/programmable drug delivery systems
has attracted significant interest in medical bionics, and the interfacial properties of the polymers, in
particular, protein adsorption characteristics, is integral to the stability of the overall performance. Herein
we report a hybrid conducting system based on polypyrrole doped with an anti-inflammatory prodrug,
dexamethasone phosphate (DexP), upon which post-surface modification was conducted to render the
polymer more biostable. We firstly investigated the influence of the current density and DexP
concentration on the physiochemical properties and surface characteristics of the resulting polymer
films. Films were then surface modified with thiolated poly(ethylene glycol). The influence of surface
modification on inhibition of nonspecific protein adsorption to the polymer surfaces was evaluated using
electrochemistry and quartz crystal microbalance. Furthermore, studies were undertaken to examine the
effect of surface coatings on the drug release behaviour triggered by electrical stimulation. Our results
demonstrated that both the physiochemical and interfacial properties of conducting polymers can be
modulated to enhance the performance of the materials as biocompatible drug delivery systems. This
provides important insight into molecular engineering of conducting polymers to facilitate their
applications in medical bionics.
Introduction
Inherently conducting polymers (ICPs) have attracted significant
interest in the area of biomaterials development due to their
inherent biocompatibility and their ability to perform multiple
biologically relevant functions.1–4 Research has been particularly
focused on the use of ICPs in medical bionic devices, such as
the cochlear implant, which is attributable to their low impe-
dance, ability to record or apply electrical stimuli to promote cell
survival, growth and differentiation, and the unique capability to
perform electrochemically controlled drug delivery. ICPs can be
used for controlled drug delivery systems through the redox
mechanism that ICPs exhibit under electrical stimulation. ICPs
incorporate anions into their backbone structures during electro-
polymerisation, which is called ‘‘doping’’, and the incorporated
anions are called ‘‘dopants’’. After electropolymerisation, when a
reduction potential is applied, the ICPs are able to eject the
doped anions, if they are suitably small enough to be expelled
from the polymer matrix. This mechanism therefore can be
employed for controlled release of anion drugs.5
While ICPs show enormous promise in medical bionics, a
number of key challenges are yet to be addressed in order to
maximise their performance in vivo. One challenge is to tune
their biocompatibility and functionality for specific applications
by modulating the material physical (i.e. modulus, interfacial
roughness) and chemical (monomer, dopant species, interfacial
chemistry) properties, providing a tailored polymer best suited
for the final application. Another major challenge is to combat
the adverse host tissue reactions associated with implantation,
including foreign body and inflammatory responses, where non-
specific protein adsorption to the device surface serves as a key
trigger, in addition to other factors such as tissue damage during
implantation and mechanical mismatch between the devices
and the surrounding tissues.6–8 It is well known that proteins
adsorb to a biomaterial surface within seconds of contact.9 Both
the composition of the adsorbed protein layer, as well as the
conformation of the surface bound protein molecules, can act in
concert to promote foreign body and inflammatory responses
through facilitating a range of biochemical cascades that may act
upon surrounding cellular and tissue function, as well as initiate
reactions from cells and tissues in direct contact with the
biomaterial itself.8 This can ultimately lead to device failure
and unexpected risks for patients.10 Critical to controlling inflam-
matory and foreign body response to implanted materials is to
develop surface coatings that minimize non-specific protein
interaction at the biomaterial interface.
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In this study, a multifunctional polypyrrole based system has
been developed to electrochemically deliver the anti-inflammatory
prodrug, dexamethasone phosphate. In addition, this system
was modified to improve the surface resistance to nonspecific
protein adsorption, which, in concert with subsequent fibrotic
tissue growth that can adversely affect biomaterials after surgery,
can impede the release and delivery of drug from the device to the
intended tissues. We investigated different conditions for the
electropolymerisation of dexamethasone sodium phosphate doped
polypyrrole (PPy/DexP) films, and their impacts on the physio-
chemical properties and the electrically-stimulated drug release
profiles of the resulting polymer films. Poly(ethylene glycol)methyl
ether thiol (PEG-SH) of different molecular weights were then
employed to modify the PPy/DexP film surface. Quartz crystal
microbalance (QCM) was used to study the PEGylation, as well




Pyrrole was purchased from Merck (Australia), and was distilled
and stored at 20 1C before use. Dexamethasone sodium
phosphate was purchased from Spectrum Chemical Mfg. Corp.
(New Brunswick, NJ). Poly(ethylene glycol)methyl ether thiol,
MW 5000 Da (PEG 5k) & 40 000 Da (PEG 40k), was purchased
from Jenkem (USA). Fibrinogen was purchased from Sigma-
Aldrich (Australia). All the other chemicals listed in this
research were from Ajax (Australia) and used as purchased.
Preparation of PPy/DexP by electropolymerisation
Monomer solutions were freshly prepared prior to electropoly-
merisation. DexP solutions were prepared in deionised water
and then deoxygenated for 30 min via bubbling with nitrogen
gas, followed by the addition of pyrrole to produce 0.2 M mono-
mer solutions.
Gold-coated Mylar films were cut into 1 cm wide stripes and
were cleaned with ethanol in a sonicating bath, then rinsed with
ethanol and deionised water and dried under nitrogen gas. The
strips were masked to leave a reactive area of 1 cm2 at one end.
PPy/DexP films were electropolymerised in a three-electrode
electrochemical cell, consisting of a Ag/AgCl reference elec-
trode, a platinum mesh counter electrode and gold-coated
Mylar as the working electrode. The electrochemical cell was
connected to an eDAQ potentiostat and controlled by eDAQ
Chart software. PPy/DexP films were grown by galvanostatic
deposition to a total charge density of 1 C cm2. Experimental
conditions were applied as shown in Table 1.
Surface modification with poly(ethylene glycol)methyl ether
thiol (PEG-SH)
The thiol groups in PEG-SH have been demonstrated to react
with the PPy backbone via a thiol–ene reaction, forming a
covalent bond, and therefore changing the surface properties of
PPy films (eqn (1)).11
In this study, PEG-SHs with two different molecular weights
(PEG 5k and PEG 40k) were assessed for surface modification.
PPy films were treated with PEG-SH by submerging each film
and supporting substrate in a 0.1 mM PEG-SH solution or by
passing the PEG-SH solution across the film surface in a flow
chamber for 30 minutes. After the PEG-SH treatment, the films
were rinsed thoroughly with deionised water and dried under
nitrogen gas for further characterisation.
Quartz crystal microbalance (QCM) characterisation
Two different QCM systems were employed in this study: an
Electrochemical QCM (EQCM) (Stanford Research Systems
QCM200), and a QCM with Dissipation monitoring (QCM-D)
Q-Sense E4 system (Q-Sense AB, Västra, Frölunda, Sweden).
EQCM was employed to characterise the mass and mechanical
properties of the PPy/DexP films as a function of electropolymer-
isation conditions in situ. The QCM-D system was used to examine
the PEG-SH modification and its influence on protein adsorption
onto the polymer films through its flow modules. The Stanford
Research Systems (SRS) EQCM employed allows the measurement
of two parameters: the frequency (f) and the resistance (R).
While the frequency provides a measure of the mass adsorbed to
the sensor surface, the resistance, which is closely related to the
dissipation (D) measurement parameter that is available on more
modern QCM-D systems, provides a measure of the viscoelastic, or
mechanical properties, of the adsorbed mass.12–14 The Sauerbrey
model was employed to quantify the mass of polymer deposited on
each QCM sensor.
The SRS QCM200 was used in conjunction with an eDAQ
potentiostat to monitor the mass deposition during electropoly-
merisation of PPy/DexP. Chromium/gold coated quartz crystals
(5 MHz, 25.4 mm in diameter) were used. The gold electrode
surface was cleaned with ethanol prior to experiments. A three-
electrode electrochemical cell was set up in the vial at the end of
the QCM probe and approximately 4 mL of fresh monomer
solution was added in the vial for each polymerisation.
The QCM-D sensor (QSX301) (4.95 MHz  50 kHz, 14 mm in
diameter) was cleaned by incubating in a Piranha solution
(concentrated sulphuric acid : 30% hydrogen peroxide (7 : 3))
for 3 minutes and rinsed thoroughly with deionised water
and dried under a stream of nitrogen gas. The QCM-D quartz
crystal sensor was then deposited with a PPy/DexP layer used as
the working electrode in a three-electrode electrochemical cell.
After polymerisation, the QCM-D sensor was removed from the
electrochemical cell and rinsed with deionised water and dried
with nitrogen gas.








A: 5 mM/0.5 mA 5 0.5 2000
B: 5 mM/1.0 mA 5 1.0 1000
C: 5 mM/1.5 mA 5 1.5 667
D: 10 mM/1.5 mA 10 1.5 667
E: 15 mM/1.5 mA 15 1.5 667
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Surface modification of PPy/DexP coatings with PEG-SH
characterised by QCM
PPy/DexP coated QCM-D sensors were transferred into the
Q-Sense axial flow module (QFM401) and equilibrated in deionised
water for 24 hours at a controlled temperature of 22 1C  0.02 1C,
with deionised water flowed through the chamber at a constant
rate of 10 mL min1. Films were equilibrated for such a period of
time to allow the frequency (f) and dissipation (D) to stabilise as
the gradual hydration of the conducting polymer layer causes the
f and D to drift. Once stable, an aqueous 0.1 mM solution of
PEG-SH was introduced into the axial flow chamber at a constant
rate of 10 mL min1 for 30 minutes where f and D reached
equilibrium. Thereafter the chamber was rinsed with deionised
water at the same flow rate until the f and D stabilised again. All
experiments were undertaken in triplicate.
Protein adsorption characterised by QCM
Fibrinogen (Fb) from human plasma was used as a model protein
for the following protein adsorption experiments. An Fb solution,
0.5 mg mL1 in 0.9% NaCl solution, was freshly prepared for each
experiment. For the study of protein adsorption on the PPy/DexP
surface, PPy/DexP coated QCM-D sensors were transferred into a
Q-Sense axial flow module (QFM401) and equilibrated with 0.9%
NaCl solution for 24 hours at 22 1C  0.02 1C and at a flow rate of
10 mL min1. The Fb solution was then introduced into the system,
at the same flow rate for 30 minutes. Thereafter the chamber was
rinsed with 0.9% NaCl solution until the f and D stabilised.
For the study of protein adsorption on PEGylated PPy/DexP
surface, subsequent to the PEG-SH modification as described
in the previous section, the QCM-D monitoring was continued
with the same procedure as described above.
Drug release
Electrically stimulated drug release was carried out in 3 mL
artificial perilymph (comprising 7.39 g L1 NaCl, 0.35 g L1
KHCO3, 2.02 g L
1 NaHCO3, 0.08 g L
1 CaCl2 and 0.61 g L
1
NH2C(CH2OH)3, with pH adjusted to 7.4) in the three-electrode cell.
During stimulated release, a constant negative potential (500 mV)
was applied to the polymer films. A 1 mL aliquot of the release
medium was withdrawn at each time point and replaced with 1 mL
of fresh artificial perilymph. The collected samples were tested with
a Shimadzu UV-1600 UV-visible spectrophotometer. Spectrum mea-
surements were performed, and the peak absorbance at 242 nm
was recorded for quantification of the amount of DexP released.
Surface characterisation
Film topography and surface roughness was characterised with an
Atomic Force Microscopy (AFM) (Asylum Research MFP 3D SA).
Images were obtained in air using intermittent contact mode with
a 10 mm 10 mm scanning area. Roughness and total surface area
were calculated using Gwyddion SPM software (version 2.34).
Electrochemistry
Electrochemistry was performed with a CHI660D potentiostat
(CH Instruments, Inc. USA) using a three-electrode set-up in
artificial perilymph. Cyclic voltammetry (CV) was carried out
between 0.8 V and 0.8 V at a scan rate of 10 mV s1, with the
initial potential at 0 V.
Statistical analysis
Data are expressed as mean  95% confidence interval, and
statistical analyses were performed with one-way ANOVA using
Minitab 17.
Results and discussion
Effect of growth condition on PPy/DexP films
Growth conditions and electrochemical properties. Two sets
of growth conditions were investigated for their influence on a
range of polymer physiochemical and electrochemical proper-
ties, as well as drug release profiles. The influence of current
density for electropolymerisation was studied by keeping a constant
DexP concentration of 5 mM while varying the current density from
0.5 mA cm2 to 1.5 mA cm2 (Table 1, A–C). The influence of DexP
concentration was studied by using a constant current density of
1.5 mA cm2, while varying the DexP concentration from 5 mM to
15 mM (Table 1, C–E). The above electropolymerisation conditions
produced 5 unique film compositions in total, as summarised in
Table 1.
CV analysis of PPy/DexP in artificial perilymph electrolyte
(Fig. 1) demonstrated a reduction peak shift between the first
cycle and second cycle, with the peaks staying constant in the
following cycles. This indicated that the complete exchange of
dopants during the first cycle. Based on the CV results, a negative
potential of500 mV was chosen for the stimulated drug release.
Mass deposition and mechanical properties. As shown in
Fig. 2A, when the DexP concentration was maintained at 5 mM,
there was no significant difference (p 4 0.1) in the total mass of
the films deposited on the QCM sensor as a function of the
current density. All the films were grown to the same charge
density (1 C cm2), and therefore it would be expected that
there would be little variation in the polymer mass as a function
of current density. While total film mass did not vary as a
function of the current density, it did vary as a function of the
concentration of the dopant DexP in the polymerisation
solution (p o 0.005) (Fig. 2A). The mass of PPy/DexP increased
Fig. 1 Cyclic voltammetry of 5 mM/0.5 mA PPy/DexP films, performed in
artificial perilymph at a scan rate of 10 mV s1 vs. Ag/AgCl.
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with an increase in DexP concentration, with a DexP concentration
of 15 mM yielding the greatest film mass (843  16 mg cm2).
This is likely due to the physical encapsulation of the dopant
anions during the polymerisation of PPy on the working elec-
trode. The higher the concentration of DexP in the poly-
merisation solution, the greater the amount of DexP physically
trapped in the polymer matrix.15 This phenomenon has been
described previously for PPy doped with the large polyanion
dextran sulphate (DS), where an increase in the concentration of
DS from 0.2 mg mL1 to 20 mg mL1 resulted in a significant
increase in total polymer mass, and was attributed to physical
entrapment of the polyanion, as opposed to an increased degree
of doping of the PPy.16
A difference in the mechanical properties of the films was
observed even though the total film mass did not vary as a
function of the current density. The mean mechanical signa-
ture, defined as the ratio of the viscoelastic properties of the
adsorbed mass (resistance) per unit of adsorbed mass (frequency)
(R/f), increased with increasing current density (Fig. 2B). As this
ratio increases, the adsorbed mass is deemed more viscoelastic,
or more hydrated and soft.17 The R/f ratio of the films grown
at 1.5 mA cm2 was significantly greater than those grown at
1.0 mA cm2 and 0.5 mA cm2.
The mechanical properties of the PPy/DexP films were also
found to vary as a function of the dopant DexP concentration.
The viscoelasticity of the polymer films grown at a DexP concen-
tration of 15 mM demonstrated a considerable decrease in
viscoelasticity compared to 5 mM and 10 mM. The films grown
at 1.5 mA cm2 demonstrated overall higher mechanical signa-
ture values than those grown at lower current densities.
Film topography. The surface roughness of PPy/DexP film
increased with an increase in current density (p o 0.005) (Fig. 3),
and decreased with an increase in the concentration of the
dopant DexP in the monomer solutions (p o 0.05). Films grown
at 1.5 mA cm2 with a DexP concentration of 5 mM demonstrated
the greatest surface roughness (203  8.8 nm).
An increase in current density has previously been shown to
increase polymer surface roughness,18,19 with this relationship
also seen in this system. However, the specific influence of a
counterion on polymer properties is known to be highly depen-
dent on the nature of the anion employed during polymer
synthesis.20 Herein surface roughness was found to significantly
Fig. 2 Mass deposition (A) and mechanical properties (B) of the PPy/DexP
films electropolymerised at different current densities and DexP concen-
trations, measured with EQCM. n = 3, error bars are representative of 95%
confidence intervals around the mean.
Fig. 3 Roughness (A) and AFM images (B) of PPy/DexP films electropolymerised at different current densities and DexP concentrations. n = 3, error bars
are representative of 95% confidence intervals around the mean.
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decrease with the increasing DexP concentration. This is consis-
tent with a recent study using the biological dopant DS which
demonstrated a decreased surface roughness and film thickness
with increasing DS concentration,17 however contrary to the pre-
vious studies that have reported an increased surface roughness of
conducting polymer as a result of increasing the dopant concen-
tration, such as p-toluene sulfonate and polystyrenesulfonate.21,22
The increased roughness obtained from increasing the
current density could be correlated to the increase of the R/f
ratio in Fig. 2, indicating an increase in viscoelasticity and
hydration of the films. This was coincident with the decreased
roughness from the reduced viscoelasticity after increasing the
dopant concentration, which indicated that the higher dopant
concentration in the monomer solution produced denser and
smoother films, behaviour that has also been observed in
similar studies elsewhere.16
Surface modification of PPy/DexP with PEG-SH
The as-prepared PPy/DexP films were surface modified with
PEG-SH, and the resulting mass changes are illustrated in
Fig. 4, which was normalised by respective polymer surface
area that was quantified using 3D AFM topographic images
(Table 2). Firstly, for all the films examined, PEGylation with
PEG 40k resulted in a larger mass change compared to those by
PEG 5k, which is indicative of more densely packed and/or
thicker PEG coating as a result of increased PEG-SH molecular
weight. When PEG 5k was employed for PEGylation, the
amount of surface anchored PEG increased with an increase
in the current density applied for electropolymerisation of
PPy/DexP films, but decreased with an increase in the dopant
concentration during electropolymerisation ( p o 0.05). How-
ever, there was no significant difference in the mass deposited
on the PPy/DexP films when PEG 40k was used for PEGylation
( p 4 0.05).
For the PEG 5k, an increase in PPy/DexP film roughness was
generally associated with an increase in PEG binding, with
greatest mass binding illustrated on 5 mM/1.5 mA films,
followed by films grown at the lower current densities (5 mM/
0.5 mA and 5 mM/1.0 mA), with the films demonstrated the
lowest roughness values (10 mM/1.5 mA and 15 mM/1.5 mA)
revealing the least PEG binding. The opposite trend was evident
for the PEG 40k, with the least mean PEG binding on the
roughest film (5 mM/1.5 mA), however, there was no significant
difference in PEG 40k binding for films grown under all growth
conditions ( p 4 0.05).
Protein adsorption on the PPy/DexP and PEGylated PPy/DexP
films
Protein adsorption onto the PPy/DexP films was evaluated
using Fb as a model protein, and using the QCM-D flow
modules. The mass adsorbed to the polymer surface was
normalised by the polymer surface area that was quantified
using 3D AFM topographic images (Table 2).
PEGylation of the PPy/DexP films, using either PEG 5k or
PEG 40k, substantially reduced Fb adsorption at the polymer
surfaces, as compared to each respective unmodified PPy/DexP
films that were prepared under the various growth conditions
(Fig. 5), except for 10 mM/1.5 mA and 15 mM/1.5 mA films
modified by PEG 5k (p 4 0.05). For the films grown in 5 mM
DexP but at various current densities, mean Fb adsorption was
the least for both 5k and 40k PEGylated PPy/DexP prepared at
1.0 mA cm2 (423  279 ng cm2 and 363  267 ng cm2 for
films modified with PEG 5k and PEG 40k, respectively). For the
films grown at a constant current density of 1.5 mA cm2 but
with various DexP concentrations, PEGylation with PEG 40k
resulted in a much more pronounced reduction in Fb adsorp-
tion (p o 0.005), compared to those with PEG 5k. Amongst
Fig. 4 PEG-SH modification of PPy/DexP films, with either PEG 5k or
PEG 40k. n = 3, error bars are representative of 95% confidence intervals
around the mean.
Table 2 Increase in the surface area of the PPy/DexP films compared to












Surface area 102.5% 104.2% 105.9% 102.8% 102.6%
Eqn (1) polypyrrole reaction with thiol group.11
Fig. 5 Fibrinogen protein adsorption against control PPy/DexP films
and PEGylated PPy/DexP films with PEG 5k and PEG 40k, measured with
QCM-D. n = 3, error bars are representative of 95% confidence intervals
around the mean.
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all the PEGylated polymer samples, PEG 40k modified films
demonstrated a consistent reduction in protein adsorption for
all polymerisation conditions, while PEG 5k modified films
showed no discernible reduction in protein adsorption for
films grown with 10 mM and 15 mM DexP.
PEGylation has been widely employed as a method through
which to protect a surface from non-specific protein interac-
tions. The anchored PEG molecules are known to function
collectively as a highly hydrated, mobile and conformationally
dynamic polymer brush layer, which presents an inert and steric
exclusion zone to the surrounding environment.23–25 A number
of variables have been demonstrated to be critical to optimising
the efficacy of the PEG layer to dissuade surface protein interac-
tions, including PEG surface grafting density and the intermole-
cular interactions/organisation of the PEG chains, which in
concert influences both surface coverage and PEG polymer brush
conformation at the substrate surface.26–28
The reactive binding of PEG-SH to PPy/DexP was charac-
terised as a function of PEG molecular weight, the current
density employed during polymer polymerisation, and the
concentration of the dopant DexP in the polymerisation elec-
trolyte (Fig. 4). The mass of PEG-SH binding was greater for
PEG 40k, relative to the PEG 5k; however, this is less than an
8 to 1 ratio that would be expected from the difference in
PEG molecular weight if the overall binding densities were the
same. Therefore it can be proposed that the binding density is
likely to be substantially less for the larger molecular weight
PEG-SH, where repulsive steric interactions for the larger
molecular weight PEG-SH prevent high surface binding densi-
ties, compared to the smaller PEG 5k. A similar mechanism has
previously been proposed to underlie the differences in total
PEG-SH binding of PEG-SH to PPy/DS films as measured via
QCM-D.17
Surface adsorbed PEG at low densities is proposed to pre-
sent a mushroom type conformation on the surface, conforma-
tionally uninhibited by neighbouring PEG molecules. In this
regime, neighbouring PEG molecules and their highly hydrated
solvation shell are not forced to overlap, and therefore there
remain gaps between the surface adsorbed PEG chains through
which suitably sized proteins may navigate to reach the under-
lying polymer surface, drawn by attractive forces including van
der Waals, electrostatic and hydrophobic interactions. Addi-
tionally, the mushroom-like conformation of PEG acts to mini-
mise the distance between the top of the PEG brush polymer
and the surface, and therefore this distance may not be
sufficient to impede attractive forces between proteins in the
interacting solution and the underlying substratum. Increasing
the PEG density on the surface decreases the space between the
PEG chains, forcing neighbouring PEG polymer brushes to
interact and overlap. Meanwhile, the repulsive intermolecular
interactions of the PEG chains forces the PEG molecules away
from each other, driving the surface bound PEG chain to extend
away from the substratum surface. The elongation of the PEG
chain forces a regime shift from a mushroom to a brush type
conformation.29 In this organisation, PEG density on the surface
is increased, reducing the likelihood of gaps between the PEG
brush layer, as well as increasing the overall height of the PEG
brush layer from the substratum surface. Increasing the mole-
cular weight of surface bound PEG, and therefore increasing the
overall chain length, has also been demonstrated to enhance
the protein resistant properties of surface bound PEG layers,
and is thought to act by increasing the overall thickness of the
PEG bound layer, and therefore sterically hindering potential
adsorbent protein molecules from reaching the underlying
surface.29
Drug release studies
DexP release profiles during the 4 hours stimulation are
demonstrated in Fig. 6, among which the 5 mM/1.5 mA films
illustrated the most DexP release. At the end of the 4 h
stimulation, the 5 mM/1.5 mA films released a mean value
of 242.0 mg cm2 of DexP, while the 5 mM/0.5 mA and 5 mM/
1.0 mA films released 70.2 mg cm2 and 85.4 mg cm2, respec-
tively. The 10 mM/1.5 mA and 15 mM/1.5 mA films released
108.4 mg cm2 and 82.1 mg cm2 of DexP respectively, which is
much less than the 5 mM/1.5 mA films. This result correlates to
the results in the roughness and mechanical properties of the
PPy/DexP films. The 5 mM/1.5 mA PPy/DexP film is shown to
have the highest surface roughness and highest R/f ratio. An
increase in surface roughness and viscoelasticity is character-
istic of a more porous and hydrated polymer film, relative to
other growth conditions. This may promote the interaction
with the electrolyte solution, and facilitate the elution of DexP
molecules from the bulk film.
Fig. 6 DexP stimulated release profiles in artificial perilymph at room
temperature of films polymerised at different current densities (A) and with
different DexP concentrations (B). n = 3, error bars are representative of
95% confidence intervals around the mean.
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The 5 mM/1.5 mA PPy/DexP films were then chosen to be
PEGylated for drug release studies. The PEG 5k and PEG 40k
modified films showed almost identical DexP release profiles
during the 4 h stimulation. However, the amount of DexP
released from PEG-SH modified films were largely reduced
(Fig. 7B). In a recent published study of PEGylation of ICPs, it
is suggested that PPy is undergoing a reduction process during
the thiol–ene reaction, and thus promote the release of mobile
dopants out of the polymer films.30 The decreased DexP release
therefore could be related to the loss of the DexP dopant during
the PEGylation process. We tested the PEG solution after
PEGylation and found UV absorption at 242 nm due to the
presence of DexP. However, the PEGylation occurs predomi-
nately at the polymer surface where the PEG-SH molecules have
access to the PPy polymer chains and therefore is not impacting
the bulk polymer material. Therefore the loss of DexP during
PEG modification is not expected to be detrimental to the drug
delivery system. Furthermore, the CV analysis showed little
change in the polymer electrochemical properties after PEGyla-
tion (Fig. 7A), demonstrating that the hydrophilic PEG layer
does not affect the ion exchange at the PPy surface and hence
the surface electroactivity. It could then be suggested that the
decreased DexP release profile is more likely attributed to the
initial loss of DexP from the PPy surface layer, and the slowed
movement of DexP from within the bulk PPy film.
Conclusion
In this work, we have demonstrated the fabrication of a hybrid
drug delivery system, with the capability of releasing an anti-
inflammatory agent as well as inhibiting protein adsorption
at the polymer surface. By varying the conditions for electro-
polymerisation, such as current density and DexP concen-
tration, PPy/DexP films with various surface morphology
and mechanical properties were obtained. Consequently,
these films exhibited different capability of Fb adsorption,
surface reactivity to PEGylation, and DexP release profiles by
electrical stimulation. PEG-SHs of two different molecular
weight (5 kDa and 40 kDa) were investigated for PEGylation
of the PPy/DexP films. Both effectively inhibited the Fb
adsorption at the resulting polymer surfaces, with the latter
producing a more pronounced effect on protein resistance.
All the PPy/DexP films demonstrated DexP release within
4 hours stimulation. The films prepared in 5 mM DexP and
at 1.5 mA cm2 released the largest amount of DexP after
4 hour stimulation.
The ability of PEGylation to reduce protein adsorption, while
largely maintaining the polymer electro-activity, has significant
implications for the development of drug eluting conducting
polymer based devices, as well as development of low fouling
conducting polymer based electrodes, which are currently the
focus of intensive research activities for a diverse suite of
biomedical applications.
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